Philadelphia, PA, United States of America

Bart C De Jonghe

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Syracuse University, University of Pennsylvania. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bart C De Jonghe. Retrieved from https://idiyas.com/inventor/bart-c-de-jonghe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bart C De Jonghe: Innovator in Peptide Ligands

Introduction

Bart C De Jonghe is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of biochemistry, particularly through his innovative work on peptide ligands.

Latest Patents

Bart holds a patent for "Peptide Ligands of the Gdnf Family Receptor A-Like (Gfral) Receptor." This patent reflects his expertise and dedication to advancing scientific knowledge in receptor biology.

Career Highlights

Throughout his career, Bart has worked with prestigious institutions such as Syracuse University and the University of Pennsylvania. His experience in these academic environments has allowed him to develop and refine his research skills.

Collaborations

Bart has collaborated with talented individuals in his field, including Matthew Robert Hayes and Tito Borner. These partnerships have contributed to the success of his research endeavors.

Conclusion

Bart C De Jonghe is a distinguished inventor whose work on peptide ligands has made a lasting impact in the scientific community. His contributions continue to inspire future innovations in biochemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…